FORTUNE BAY MOVES INTO 2026 FOCUSED ON EXPEDITED ADVANCEMENT OF GOLDFIELDS

Fortune Bay Corp. (TSXV: FOR) (FWB: 5QN) (OTCQB: FTBYF) ("Fortune Bay" or the "Company") is entering 2026 with a strengthened ...

Defense Metals Appoints Robin Jones as Vice President, Projects

Defense Metals Corp. ("Defense Metals" or the "Company"; (TSXV: DEFN) (OTCQB: DFMTF) (FSE:35D) is pleased to announce the appointment of Robin Jones as Vice President, Projects.

Mayfair Gold to Commence Trading on the NYSE American Under the Ticker "MINE" on January 27, 2026

Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSX-V: MFG; OTCQX: MFGCD) is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the ...
Le Lézard

Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2…

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it has submitted a Biologics License ...
Cure Today

Piqray Plus Faslodex Improves PFS in Advanced Breast Cancer

Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer after CDK4/6 inhibitor treatment. The EPIK-B5 study reported a median ...

Freegold Provides an Update on its 2026 Plans

Freegold Ventures Limited ("Freegold" or "the Company") (TSX: FVL) (OTCQX: FGOVF) is pleased to provide an update on its 2026 ...

Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs

PRNewswire/ -- (Middletown, Delaware) a leading provider of high-value, system-critical elastomer components, announced a ...
The Malaysian Reserve

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The oncology landscape is ...

Genmab A/S: Genmab Announces Net Sales of DARZALEX (daratumumab) for 2025

Company Announcement Net sales of DARZALEX- in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAG ...
Agence France-Presse

Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma

Incyte (Nasdaq:INCY) today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi ® /Minjuvi ®), a humanized Fc-modified ...
MyHorryNews

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates

Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash and cash equivalents of approximately $261M as of December 31, 2025, provi ...
Barron's

Provident Financial Services Inc.

About Provident Financial Services Inc. Provident Financial Services, Inc. is a holding company, which engages in the provision of banking services to individual and corporate customers in Northern ...